Inogen (INGN) Reports Q1 EPS of $0.07; Boosts FY15 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Inogen (INGN) PT Lifted to $46 at Needham & Company
April 27, 2015 11:56 AM EDTNeedham & Company analyst Mike Matson reiterated a Strong Buy rating and bumped his price target on Inogen, Inc (NASDAQ: INGN) to $46.00 (from $45.00) following strong Q4 results.
Matson commented, "INGN beat consensus in 4Q14 and raised its 2015 revenue guidance. Growth remained strong across INGN's sales... More
